Insider Trading
Aldeyra Therapeutics Insider Bought Shares Worth $418,450, According to a Recent SEC Filing
Todd C Brady, Director, President and CEO, on June 03, 2026, executed a purchase for 250,000 shares in Aldeyra Therapeutics (ALDX) for $418,450. Following the Form 4 filing with the SEC, Brady has control over a total of 1,721,298 common shares of the company, with 1,721,298 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1341235/000119312526259637/xslF345X05/ownership.xml
$ALDX
